{"url_path":"/sec/apm/8-k/2026-07-20/item-3-03","section_key":"item-3-03","section_title":"Item 3.03 Material Modifications to Rights of Security Holders.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1734005/0001213900-26-079416-index.html","accession_number":"0001213900-26-079416","cik":"0001734005","ticker":"APM","issuer_name":"Niki BioSolutions, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1734005/0001213900-26-079416-index.html","primary_entity_key":"0001734005","primary_entity_name":"Niki BioSolutions, Inc."},"word_count":424,"has_tables":true,"body_markdown":"**Item\n3.03 Material Modifications to Rights of Security Holders.**\n\n \n\nThe disclosure set forth in Item 2.01 of this\nCurrent Report is incorporated herein by reference.\n\n \n\nAs of July 20, 2026, Aptorum effectuated a 10\nfor 1 share consolidation of its authorized share capital, such that every 10 Class A Ordinary Shares, par value of US$0.00001 per share,\nin the authorized share capital of Aptorum (including issued and unissued share capital) be consolidated into 1 Class A Ordinary Share,\npar value of US$0.0001 per share, and that every 10 Class B Ordinary Shares, par value of US$0.00001 per share in the authorized share\ncapital of Aptorum (including issued and unissued share capital) be consolidated into 1 Class B Ordinary Share, par value of US$0.0001\nper share (the “Share Consolidation” or “Reverse Split”).\n\n \n\nThe Reverse Split was approved by the Company’s\nshareholders on June 9, 2026 and Aptorum’s board of directors approved implementing the Reverse Split effective as of July 20, 2026.\nAccordingly, the Reverse Split was effective and the Class A Ordinary Shares began trading on a split-adjusted basis when the market opened\non July 20, 2026.\n\n \n\nImmediately prior to the Share Consolidation, Aptorum had 6,346,823 Class\nA Ordinary Shares outstanding and 1,796,934 Class B Ordinary Shares outstanding. Following the Share Consolidation, there are 634,682\nClass A Ordinary Shares outstanding and 179,693 Class B Ordinary Shares outstanding (these numbers are based on the current number of\nshares outstanding and are subject to change, in either direction, once the Reverse Split is effected on an individual basis). As a result\nof the Reverse Split, the Company’s authorized share capital was US$100,000,000 divided into 999,999,600 Class A Ordinary Shares\nwith a par value of US$0.0001 each and 400,000 Class B Ordinary Shares with a par value of US$0.0001 each.\n\n \n\nIn connection with the Merger, the Company adopted\na set of Bylaws. The material terms of the Company’s Certificate of Incorporation and Bylaws and the general effect upon the rights\nof holders of Niki Common Stock are discussed in the Proxy Statement/Prospectus in the section titled “*The Domestication Proposal*”\nbeginning on page 106, which is incorporated herein by reference. Reference is also made to the sections of the Proxy Statement/Prospectus\ntitled “*Description of Share Capital – Aptorum Delaware*” and “*Comparison of Corporate Governance and\nShareholder Rights*” beginning on pages 255 and 257 respectively, which are incorporated herein by reference. Reference is also\nmade to the sections of the Proxy Statement/Prospectus titled “*Proposal No. 1 - Share Consolidation Proposal*” beginning\non page 102, which is incorporated herein by reference."}